SRI and cancer: Sorcin can be considered an oncogene and a marker of multidrug resistance (MDR), since its overexpression confers MDR in cancer cell line models, while its silencing increases sensitivity to chemotherapeutic drugs [33, 38, 43, 45–47, 49, 52–54].